'Exciting breakthrough': COVID-19 drug trial to take place in Edmonton
Trials for a Canadian-developed COVID-19 treatment are set to begin at the University of Alberta.
The study will evaluate the safety and efficacy of the drug Apabetalone as a potential oral medication to help prevent severe infection from COVID-19.
“It’s a pretty exciting breakthrough,” Donald McCaffrey, the president and CEO of Resverlogix, said.
The clinical program will test epigenetics on COVID-19 patients, including those who were sick with a variant strain.
“The genetics is the hardware, the epigenetics is the software. The science of learning to turn on or off various genes,” McCaffrey explained.
The drug has been in development for more than 20 years and when COVID-19 emerged, a group of universities began studying drugs already in production that could be repurposed to help fight COVID-19. Apabetalone ended up being “number two on the list,” according to McCaffrey.
“We do have a huge lead on the world in knowledge on this (protein) and how to remove it.”
The drug is an oral pill taken once in the morning and once at night. A total of 100 patients are expected to be enrolled over the coming week to take part in the trial at various sites in Canada and Brazil.
“By removing the bromodomain (BD2) and shutting down the ACE2 receptors, you’re greatly inhibiting the virus’s ability to reproduce,” McCaffrey shared.
'WE DO NOT CHANGE THE HUMAN DNA'
The average COVID-19 hospital stay right now is 11.9 days, McCaffrey told CTV News Edmonton. That stay increases up to 23 days if the patient has cardiovascular issues. He said the cost can range from $26,000 to $52,000 per patient receiving care.
“The goal is to show that we can remove the long hospital stays.”
McCaffrey said because of Apabetalone’s unique epigenetic mechanism, it has the ability to stop disease progression by regulating the “expression” of disease and inflammation-causing genes.
“We do not change the human DNA; it remains identical,” he said. “But, we do turn the genes on or off, and that has a huge therapeutic benefit for our patients.”
In addition to reducing the duration of the disease, the hope is that the drug will also potentially be able to protect those infected from the long-term effects of long-COVID.
'IT WILL BE EFFECTIVE'
Apabetalone would cost about $7 per pill and should be taken for two to three weeks, McCaffrey said.
If the trials are successful, the team's next step would be to apply for an emergency management application in Canada in June, and then in the U.S. about six months later, McCaffrey explained.
“The vaccine is the most important thing at the moment,” Dr. Noel Gibney, professor emeritus, critical care medicine at the U of A, added. “But, we know that even with vaccination, people with critically poor immune systems are still at risk. So, it really is important that we have other therapies.”
With years of data backing the science, efficacy and safety of the drug, McCaffrey is confident it could help “manage the real problem,” which he says is the “bottleneck” in hospitals.
“No matter what Greek alphabet we get hit with next, it will be effective against all future variants.”
With files from CTV News Edmonton’s Carlyle Fiset
CTVNews.ca Top Stories
Nanos survey says most Canadians support expansion of Old Age Security benefits, but economic experts call it 'terrible policy'
Amid new polling indicating most Canadians support boosting Old Age Security benefits by 10 per cent for seniors aged 65 to 74, a former Liberal finance minister and former Bank of Canada governor are warning the government not to pursue the policy change.
'You were innocent': Judge acquits Manitoba man 50 years after murder conviction
A Manitoba man convicted of murder 50 years ago has been acquitted. Clarence Woodhouse was found guilty in 1974 of fatally beating and stabbing a restaurant worker in downtown Winnipeg.
Health official confirms death of Ontario child following rabies diagnosis
An Ontario child has died after coming in contact with a rabid bat, a health official confirmed on Wednesday.
Los Angeles prosecutors to review new evidence in Menendez brothers' 1996 murder conviction
Prosecutors in Los Angeles are reviewing new evidence in the case of Erik and Lyle Menendez to determine whether they should be serving life sentences for killing their parents in their Beverly Hills mansion more than 35 years ago, the city's district attorney said Thursday.
Garth Brooks accused of rape in lawsuit from hair-and-makeup artist
A woman who says she worked as a hair-and-makeup stylist for Garth Brooks alleged in a lawsuit filed Thursday that he raped her in a Los Angeles hotel in 2019.
Melania Trump says she supports abortion rights, putting her at odds with the GOP
Melania Trump revealed her support for abortion rights Thursday ahead of the release of her upcoming memoir, exposing a stark contrast with her husband, Republican presidential nominee Donald Trump, on the crucial election issue.
Parliament 'ground to a halt' over Conservative allegations of Liberal corruption
Government business has been put on indefinite pause in the House of Commons and the Conservatives say it will stay that way until the Liberals hand over documents related to misspent government dollars.
Breast cancer patient says she had to lie to get a mammogram in Ontario
When an Ontario doctor refused to sign off on a mammogram for 38-year-old Sidra Lone, the mother of four says she was left with no choice but to lie.
184 passengers and crew evacuated as Ryanair Boeing plane catches fire on runway in Italy
More than 180 people were evacuated Thursday from a Ryanair Boeing passenger jet after it caught fire while taxiing to take off at Brindisi Airport in southern Italy.